With Biovac agreement, Pfizer and BioNTech extend their COVID-19 vaccine manufacturing network to Africanews2021-07-21T14:43:05+00:00July 21st, 2021|Fierce Pharma|
Is Entresto maker Novartis scared of Jardiance’s landmark heart failure win? Not really, exec saysnews2021-07-21T14:34:53+00:00July 21st, 2021|Fierce Pharma|
Teva taps new North American commercial chief as key meds Ajovy, Austedo lag their rivalsnews2021-07-21T13:42:49+00:00July 21st, 2021|Fierce Pharma|
Catalent makes a $100M splash to add biologics drug substance firepower at Italian plantnews2021-07-21T13:16:29+00:00July 21st, 2021|Fierce Pharma|
Bluebird bio, reeling from Zynteglo safety scare, snags EU nod for new gene therapy against rare neurodegenerative diseasenews2021-07-21T12:05:53+00:00July 21st, 2021|Fierce Pharma|
Otezla maker Amgen challenges patient groups to help fix long-lasting psoriasis treatment gapsnews2021-07-21T11:24:57+00:00July 21st, 2021|Fierce Pharma|
Albireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europenews2021-07-20T21:09:14+00:00July 20th, 2021|Fierce Pharma|
Alexion’s new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal loomsnews2021-07-20T15:28:41+00:00July 20th, 2021|Fierce Pharma|
Scandal aside, Biogen’s Aduhelm sales set to reach $1B next year and $6B+ by 2025: analystsnews2021-07-20T15:23:50+00:00July 20th, 2021|Fierce Pharma|
Johnson & Johnson and 3 distributors ready to settle opioid lawsuits for $26B: reportnews2021-07-20T14:38:32+00:00July 20th, 2021|Fierce Pharma|
